Clinical Trials

NCT04661982 | ACTIVE_NOT_RECRUITING

500 participants

Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2010-07-06

Completion:

2026-11-24

Conditions

• Breast Cancer

Interventions

• OTHER

No Results Yet

NCT04636307 | COMPLETED

202 participants

Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2021-09-22

Completion:

2023-03-21

Conditions

• NPDR - Non Proliferative Diabetic Retinopathy
• Diabetes Mellitus, Type 2
• Retinal Disease

Interventions

• OTHER

No Results Yet

NCT04625647 | ACTIVE_NOT_RECRUITING | PHASE2

116 participants

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2021-04-16

Completion:

2026-12-31

Conditions

• Lung Adenocarcinoma
• Lung Non-Small Cell Carcinoma
• Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
• Stage IV Lung Cancer AJCC v8
• Stage IVA Lung Cancer AJCC v8
• Stage IVB Lung Cancer AJCC v8

Interventions

• DRUG

No Results Yet

NCT04590404 | COMPLETED | PHASE3

606 participants

Metabolism Informed Smoking Treatment: The MIST RCT

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2020-11-17

Completion:

2024-05-20

Conditions

• Smoking

Interventions

• BEHAVIORAL
• DRUG
• OTHER

Results Available

NCT04570943 | RECRUITING | PHASE2

103 participants

Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2021-06-16

Completion:

2028-01-31

Conditions

• Locally Advanced Pancreatic Adenocarcinoma

Interventions

• COMBINATION_PRODUCT
• RADIATION

No Results Yet

NCT04559815 | COMPLETED

194 participants

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2020-10-21

Completion:

2022-09-14

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT04556344 | COMPLETED | NA

26 participants

Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2020-10-26

Completion:

2023-01-05

Conditions

• Digestive System Neoplasms
• Thoracic Neoplasms

Interventions

• BEHAVIORAL

No Results Yet

NCT04546126 | RECRUITING | EARLY_PHASE1

24 participants

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2021-11-01

Completion:

2026-12-31

Conditions

• Radiotracer
• Hypertension
• Cholesterol

Interventions

• DRUG
• COMBINATION_PRODUCT

No Results Yet

NCT04532489 | RECRUITING | EARLY_PHASE1

6 participants

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2021-01-18

Completion:

2026-12-31

Conditions

• Radiotracer
• Hypertension
• Cholesterol

Interventions

• DRUG

No Results Yet

NCT04501913 | COMPLETED

22 participants

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2019-12-24

Completion:

2025-10-17

Conditions

• Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
• Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage 0 Gastric Cancer AJCC v8
• Clinical Stage I Esophageal Adenocarcinoma AJCC v8
• Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage I Gastric Cancer AJCC v8
• Clinical Stage II Esophageal Adenocarcinoma AJCC v8
• Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage II Gastric Cancer AJCC v8
• Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IIA Gastric Cancer AJCC v8
• Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IIB Gastric Cancer AJCC v8
• Clinical Stage III Esophageal Adenocarcinoma AJCC v8
• Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage III Gastric Cancer AJCC v8
• Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage IV Gastric Cancer AJCC v8
• Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage IVA Gastric Cancer AJCC v8
• Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage IVB Gastric Cancer AJCC v8
• Hepatobiliary Neoplasm
• Malignant Digestive System Neoplasm
• Malignant Female Reproductive System Neoplasm
• Malignant Genitourinary System Neoplasm
• Malignant Neoplasm
• Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage 0 Gastric Cancer AJCC v8
• Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage I Gastric Cancer AJCC v8
• Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IA Gastric Cancer AJCC v8
• Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IB Gastric Cancer AJCC v8
• Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage II Gastric Cancer AJCC v8
• Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IIA Gastric Cancer AJCC v8
• Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IIB Gastric Cancer AJCC v8
• Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage III Gastric Cancer AJCC v8
• Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IIIA Gastric Cancer AJCC v8
• Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IIIB Gastric Cancer AJCC v8
• Pathologic Stage IIIC Gastric Cancer AJCC v8
• Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IV Gastric Cancer AJCC v8
• Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
• Stage 0 Colorectal Cancer AJCC v8
• Stage 0a Bladder Cancer AJCC v8
• Stage 0is Bladder Cancer AJCC v8
• Stage I Bladder Cancer AJCC v8
• Stage I Cervical Cancer AJCC v8
• Stage I Colorectal Cancer AJCC v8
• Stage I Ovarian Cancer AJCC v8
• Stage I Prostate Cancer AJCC v8
• Stage I Renal Cell Cancer AJCC v8
• Stage I Uterine Corpus Cancer AJCC v8
• Stage IA Cervical Cancer AJCC v8
• Stage IA Ovarian Cancer AJCC v8
• Stage IA Uterine Corpus Cancer AJCC v8
• Stage IA1 Cervical Cancer AJCC v8
• Stage IA2 Cervical Cancer AJCC v8
• Stage IB Cervical Cancer AJCC v8
• Stage IB Ovarian Cancer AJCC v8
• Stage IB Uterine Corpus Cancer AJCC v8
• Stage IB1 Cervical Cancer AJCC v8
• Stage IB2 Cervical Cancer AJCC v8
• Stage IC Ovarian Cancer AJCC v8
• Stage II Bladder Cancer AJCC v8
• Stage II Cervical Cancer AJCC v8
• Stage II Colorectal Cancer AJCC v8
• Stage II Ovarian Cancer AJCC v8
• Stage II Prostate Cancer AJCC v8
• Stage II Renal Cell Cancer AJCC v8
• Stage II Uterine Corpus Cancer AJCC v8
• Stage IIA Cervical Cancer AJCC v8
• Stage IIA Colorectal Cancer AJCC v8
• Stage IIA Ovarian Cancer AJCC v8
• Stage IIA Prostate Cancer AJCC v8
• Stage IIA1 Cervical Cancer AJCC v8
• Stage IIA2 Cervical Cancer AJCC v8
• Stage IIB Cervical Cancer AJCC v8
• Stage IIB Colorectal Cancer AJCC v8
• Stage IIB Ovarian Cancer AJCC v8
• Stage IIB Prostate Cancer AJCC v8
• Stage IIC Colorectal Cancer AJCC v8
• Stage IIC Prostate Cancer AJCC v8
• Stage III Bladder Cancer AJCC v8
• Stage III Cervical Cancer AJCC v8
• Stage III Colorectal Cancer AJCC v8
• Stage III Ovarian Cancer AJCC v8
• Stage III Prostate Cancer AJCC v8
• Stage III Renal Cell Cancer AJCC v8
• Stage III Uterine Corpus Cancer AJCC v8
• Stage IIIA Bladder Cancer AJCC v8
• Stage IIIA Cervical Cancer AJCC v8
• Stage IIIA Colorectal Cancer AJCC v8
• Stage IIIA Ovarian Cancer AJCC v8
• Stage IIIA Prostate Cancer AJCC v8
• Stage IIIA Uterine Corpus Cancer AJCC v8
• Stage IIIA1 Ovarian Cancer AJCC v8
• Stage IIIA2 Ovarian Cancer AJCC v8
• Stage IIIB Bladder Cancer AJCC v8
• Stage IIIB Cervical Cancer AJCC v8
• Stage IIIB Colorectal Cancer AJCC v8
• Stage IIIB Ovarian Cancer AJCC v8
• Stage IIIB Prostate Cancer AJCC v8
• Stage IIIB Uterine Corpus Cancer AJCC v8
• Stage IIIC Colorectal Cancer AJCC v8
• Stage IIIC Ovarian Cancer AJCC v8
• Stage IIIC Prostate Cancer AJCC v8
• Stage IIIC Uterine Corpus Cancer AJCC v8
• Stage IIIC1 Uterine Corpus Cancer AJCC v8
• Stage IIIC2 Uterine Corpus Cancer AJCC v8
• Stage IV Bladder Cancer AJCC v8
• Stage IV Cervical Cancer AJCC v8
• Stage IV Colorectal Cancer AJCC v8
• Stage IV Ovarian Cancer AJCC v8
• Stage IV Prostate Cancer AJCC v8
• Stage IV Renal Cell Cancer AJCC v8
• Stage IV Uterine Corpus Cancer AJCC v8
• Stage IVA Bladder Cancer AJCC v8
• Stage IVA Cervical Cancer AJCC v8
• Stage IVA Colorectal Cancer AJCC v8
• Stage IVA Ovarian Cancer AJCC v8
• Stage IVA Prostate Cancer AJCC v8
• Stage IVA Uterine Corpus Cancer AJCC v8
• Stage IVB Bladder Cancer AJCC v8
• Stage IVB Cervical Cancer AJCC v8
• Stage IVB Colorectal Cancer AJCC v8
• Stage IVB Ovarian Cancer AJCC v8
• Stage IVB Prostate Cancer AJCC v8
• Stage IVB Uterine Corpus Cancer AJCC v8
• Stage IVC Colorectal Cancer AJCC v8

Interventions

• PROCEDURE
• OTHER

No Results Yet

NCT04497779 | ACTIVE_NOT_RECRUITING

95 participants

Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2020-07-13

Completion:

2026-10-13

Conditions

• Asymptomatic COVID-19 Infection Laboratory-Confirmed
• Symptomatic COVID-19 Infection Laboratory-Confirmed

Interventions

• PROCEDURE
• OTHER

No Results Yet

NCT04464421 | COMPLETED | NA

48 participants

SMART Effectiveness Trial

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2020-08-17

Completion:

2021-07-30

Conditions

• Opioid-use Disorder
• Opioid Dependence
• Treatment Adherence

Interventions

• BEHAVIORAL

Results Available

NCT04416191 | RECRUITING | NA

45 participants

Immune Cells During Disuse and Recovery

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2022-05-15

Completion:

2027-04-30

Conditions

• Muscle Disuse

Interventions

• OTHER

No Results Yet

NCT04391062 | COMPLETED | PHASE2

14 participants

Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2021-09-28

Completion:

2024-03-25

Conditions

• Glioblastoma

Interventions

• DRUG
• DEVICE

No Results Yet

NCT04369807 | COMPLETED

693 participants

Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2020-04-21

Completion:

2022-04-19

Conditions

• COVID-19

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT04360005 | AVAILABLE

Managed Access Programs for ABL001, Asciminib

Study Type:

EXPANDED_ACCESS

Last Updated:

2025-12-05

Conditions

• Chronic Myeloid Leukemia in Chronic Phase

Interventions

• DRUG

No Results Yet

NCT04334070 | AVAILABLE

Lamprene Multiple Patient Program

Study Type:

EXPANDED_ACCESS

Last Updated:

2025-12-05

Conditions

• Non-Tuberculous Mycobacterial (NTM) Infections

Interventions

• DRUG

No Results Yet

NCT04259203 | COMPLETED | NA

33 participants

Efficacy of Ericksonian Hypnosis in the Management of Chronic Pain Related to Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2020-08-08

Completion:

2024-08-16

Conditions

• Parkinson Disease
• Chronic Pain

Interventions

• BEHAVIORAL

No Results Yet

NCT04238637 | ACTIVE_NOT_RECRUITING | PHASE2

50 participants

Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-11-01

Completion:

2026-08-31

Conditions

• Intrahepatic Cholangiocarcinoma

Interventions

• DRUG

No Results Yet

NCT04184050 | ACTIVE_NOT_RECRUITING | PHASE1

100 participants

Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2020-04-13

Completion:

2026-12-31

Conditions

• Multiple Myeloma in Relapse
• Multiple Myeloma
• Multiple Myeloma of Bone
• Multiple Myeloma With Failed Remission

Interventions

• DRUG

No Results Yet

NCT04176302 | COMPLETED | NA

173 participants

Monitoring of Mobility of Parkinson's Patients for Therapeutic Purposes - Clinical Trial

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-11-26

Completion:

2022-12-31

Conditions

• Parkinson Disease

Interventions

• DEVICE
• DIAGNOSTIC_TEST
• OTHER

No Results Yet

NCT04171674 | COMPLETED | NA

12 participants

Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2021-04-01

Completion:

2023-01-04

Conditions

• Pneumonia

Interventions

• DRUG

No Results Yet

NCT04166825 | RECRUITING | NA

300 participants

Ovarian Hyperstimulation and Fibrin Clot Properties.

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-11-18

Completion:

2026-01-31

Conditions

• Fibrin Blood Clot
• Infertility, Female
• Endometriosis

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT04141878 | RECRUITING | NA

400 participants

Dementia and Diabetes Prevention Program

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2021-05-26

Completion:

2026-06-27

Conditions

• Diabetes
• Dementia

Interventions

• BEHAVIORAL

No Results Yet

NCT04113759 | RECRUITING | NA

56 participants

Blood Flow Restriction Following Hip Arthroscopy

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2023-08-01

Completion:

2027-11-30

Conditions

• Labral Tear, Glenoid
• Femoral Acetabular Impingement

Interventions

• BEHAVIORAL

No Results Yet

NCT04106531 | TERMINATED

8 participants

Validation of a Quality of Life Metric "Prolac-10"

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2019-10-15

Completion:

2023-06-13

Conditions

• Prolactinoma
• Prolactin-Producing Pituitary Tumor
• Pituitary Tumor
• Prolactinoma Macroadenoma
• Prolactinoma Microadenoma

No Results Yet

NCT03987295 | COMPLETED | PHASE2

33 participants

A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-09-27

Completion:

2024-06-05

Conditions

• Frontotemporal Dementia

Interventions

• DRUG

Results Available

NCT03968653 | TERMINATED | PHASE1

76 participants

Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-07-30

Completion:

2025-10-23

Conditions

• Advanced Solid Tumors

Interventions

• DRUG

No Results Yet

NCT03921827 | COMPLETED | NA

130 participants

External Counterpulsation Therapy for Severe Steno-occlusive Intracranial Stenosis

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-01-08

Completion:

2024-03-30

Conditions

• Ischemic Stroke

Interventions

• DEVICE

No Results Yet

NCT03898531 | COMPLETED

55 participants

Mineral Nano Pathology

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2019-08-11

Completion:

2024-07-09

Conditions

• Arthroplasty

Interventions

• PROCEDURE

No Results Yet

NCT03865771 | RECRUITING | NA

95 participants

Sleep Related Memory Consolidation in Children With Age Related Focal Epilepsy.

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-03-27

Completion:

2027-09-30

Conditions

• Benign Epilepsy With Centro Temporal Spikes (BECTS)
• Atypical Benign Partial Epilepsy (ABPE)
• Epileptic Encephalopathy With Continuous Spike and Waves During Sleep (ECSWS)

Interventions

• BEHAVIORAL
• OTHER

No Results Yet

NCT03802617 | COMPLETED | PHASE2

247 participants

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-02-01

Completion:

2019-10-22

Conditions

• Uremic Pruritus

Interventions

• DRUG

Results Available

NCT03764150 | COMPLETED

113 participants

Factors Associated With Hypoventilation in the Myotonic Dystrophy, Progressive Profile Over 5 Years

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2010-06-30

Completion:

2023-06-11

Conditions

• Myotonic Dystrophy, Steinert

No Results Yet

NCT03763448 | COMPLETED | NA

377 participants

Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty(IPAKA)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2018-12-17

Completion:

2024-05-13

Conditions

• Knee Osteoarthritis
• Arthropathy of Knee

Interventions

• PROCEDURE

No Results Yet

NCT03759015 | ACTIVE_NOT_RECRUITING | NA

10 participants

Evaluation of Health Education Theater

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-04-03

Completion:

2020-12-31

Conditions

• Community Health Education

Interventions

• BEHAVIORAL

No Results Yet

NCT03735121 | COMPLETED | PHASE3

438 participants

A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2018-12-27

Completion:

2022-04-26

Conditions

• Non-Small Cell Lung Cancer

Interventions

• DRUG

Results Available

NCT03725605 | COMPLETED | PHASE2

6 participants

LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2018-12-28

Completion:

2021-07-02

Conditions

• Soft Tissue Sarcoma

Interventions

• COMBINATION_PRODUCT

Results Available

NCT03678831 | COMPLETED

45 participants

Characteristics of Marrow Fatty Cells in the Ageing of Bone and Joints, Osteoarthritis and Osteoporosis

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-05

Start Date:

2020-06-30

Completion:

2024-03-11

Conditions

• Osteoarthritis, Knee
• Prosthesis User

Interventions

• PROCEDURE

No Results Yet

NCT03668223 | COMPLETED | NA

195 participants

The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-04-15

Completion:

2024-01-23

Conditions

• Cancer
• Quality of Life
• Anxiety
• Depression
• Hope
• Coping Skills
• Communication

Interventions

• BEHAVIORAL

Results Available

NCT03620903 | ACTIVE_NOT_RECRUITING | PHASE2

53 participants

Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-05

Start Date:

2019-09-11

Completion:

2022-11-14

Conditions

• Waldenstrom Macroglobulinemia

Interventions

• DRUG

No Results Yet